Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Overcoming economic barriers to the optimal use of vaccines.

Lieu TA, McGuire TG, Hinman AR.

Health Aff (Millwood). 2005 May-Jun;24(3):666-79.

2.

The problems and promise of vaccine markets in developing countries.

Batson A.

Health Aff (Millwood). 2005 May-Jun;24(3):690-3.

4.

WHO expectation and industry goals.

Vandersmissen W.

Vaccine. 2001 Feb 8;19(13-14):1611-5.

PMID:
11166883
5.

Global perspectives on vaccine financing.

Berman S, Giffin RB.

Expert Rev Vaccines. 2004 Oct;3(5):557-62. Review.

PMID:
15485335
7.
8.

Vaccines, global health and social equity.

Levine MM, Robins-Browne R.

Immunol Cell Biol. 2009 May-Jun;87(4):274-8. doi: 10.1038/icb.2009.15. Review.

PMID:
19308074
9.
10.

Second National Immunization Congress 2010: addressing vaccine financing for the future in the US.

Shen AK, Sobzcyk E, Buchanan A, Wu L, Duggan-Goldstein S.

Hum Vaccin. 2011 Jan 1;7(1):12-8.

PMID:
21178397
11.

Vaccines as a global imperative--a business perspective.

Stéphenne J.

Health Aff (Millwood). 2011 Jun;30(6):1042-8. doi: 10.1377/hlthaff.2011.0338.

12.

Vaccine procurement and self-sufficiency in developing countries.

Woodle D.

Health Policy Plan. 2000 Jun;15(2):121-9.

13.

Long-term solutions for the problem of vaccine shortages.

Lattanzi M, Rappuoli R.

Expert Opin Biol Ther. 2004 Jun;4(6):989-92.

PMID:
15174980
14.

Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.

Cook J, Jeuland M, Maskery B, Lauria D, Sur D, Clemens J, Whittington D.

J Policy Anal Manage. 2009 Winter;28(1):6-28.

PMID:
19090047
15.

What are today's orphaned vaccines?

Wilde H.

Clin Infect Dis. 2001 Sep 1;33(5):648-50.

16.

The introduction of new vaccines into developing countries. III. The role of intellectual property.

Mahoney RT, Pablos-Mendez A, Ramachandran S.

Vaccine. 2004 Jan 26;22(5-6):786-92.

PMID:
14741174
17.

Economic aspects of vaccines and immunizations.

Hinman AR.

C R Acad Sci III. 1999 Nov;322(11):989-94. Review.

PMID:
10646095
18.

The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.

Jadhav S, Datla M, Kreeftenberg H, Hendriks J.

Vaccine. 2008 Mar 20;26(13):1611-5. doi: 10.1016/j.vaccine.2008.01.034. Review.

PMID:
18294742
19.

Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries.

Batson A, Meheus F, Brooke S.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/219-25. Review.

PMID:
16950010
20.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

Items per page

Supplemental Content

Support Center